Sign Up to like & get
recommendations!
0
Published in 2024 at "Clinical Pharmacology and Therapeutics"
DOI: 10.1002/cpt.3591
Abstract: The KEYNOTE‐0421,2 trial showed the benefit of treating patients with non‐oncogene addicted advanced NSCLC with PD‐L1 tumor proportion score over 50% with pembrolizumab as monotherapy over platinum‐doublet chemotherapy. To contextualize these results, we undertake a…
read more here.
Keywords:
pembrolizumab;
chemotherapy;
population;
comparative effectiveness ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Interventional Cardiac Electrophysiology"
DOI: 10.1007/s10840-019-00624-w
Abstract: PurposeAntitachycardia pacing (ATP) terminates the majority (but not all) of slow ventricular tachycardias (S-VT) with a cycle length (CL) > 320 ms. Usually, several ATP therapies are programmed in the S-VT zone. Our objective is to…
read more here.
Keywords:
atp;
atp atp;
effectiveness first;
ppi tcld ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Future Oncology"
DOI: 10.1080/14796694.2024.2385882
Abstract: Aim: Renal cell carcinoma (RCC) is the seventh commonest cancer in the UK, where first-line (1L) sunitinib and second-line (2L) axitinib are treatment options. Methods: Retrospective, non-interventional data from the Christie NHS Foundation Trust (Manchester,…
read more here.
Keywords:
real world;
first second;
effectiveness first;
second line ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "AIDS"
DOI: 10.1097/qad.0000000000002254
Abstract: OBJECTIVE We aimed to assess the effectiveness of first-line antiretroviral therapy (ART) regimens in achieving viral suppression at 12 months, from 2014 to 2017 in Brazil. DESIGN Retrospective cohort study utilizing programmatic data from the…
read more here.
Keywords:
effectiveness first;
dolutegravir;
viral suppression;
cohort ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.14472
Abstract: Poor efficacy has been reported for patients with BRAF mutations for metastatic colorectal cancer (mCRC).
read more here.
Keywords:
metastatic colorectal;
first line;
colorectal cancer;
effectiveness first ... See more keywords